Education
About Us
Working with TipRanks
Follow Us
Grifols, SA (GB:0RDV)
LSE:0RDV
0RDV Stock Chart & Stats
Day’s Range― - ―
52-Week Range€5.51 - €9.47
Previous CloseN/A
Volume658.00
Average Volume (3M)7.73K
Market Cap
€6.44B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)11.07B
Price to Earnings (P/E)27.1
Beta1.58
Next Earnings
Jul 24, 2025EPS Estimate
0.2Last Dividend Ex-Date
Jun 03, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding261,425,100
10 Day Avg. Volume13,432
30 Day Avg. Volume7,731
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€15.25Price Target Upside99.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Grifols News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.55%
Mutual Funds
0.02% Other Institutional Investors
93.53% Public Companies and
Individual Investors
0RDV FAQ
What was Grifols, SA’s price range in the past 12 months?
Grifols, SA lowest share price was €5.50 and its highest was €9.46 in the past 12 months.
What is Grifols, SA’s market cap?
Grifols, SA’s market cap is €6.44B.
When is Grifols, SA’s upcoming earnings report date?
Grifols, SA’s upcoming earnings report date is Jul 24, 2025 which is in 33 days.
How were Grifols, SA’s earnings last quarter?
Grifols, SA released its earnings results on May 12, 2025. The company reported €0.088 earnings per share for the quarter, missing the consensus estimate of €0.139 by -€0.051.
Is Grifols, SA overvalued?
According to Wall Street analysts Grifols, SA’s price is currently Undervalued.
Does Grifols, SA pay dividends?
Grifols, SA pays a Annually dividend of €0.008 which represents an annual dividend yield of N/A. See more information on Grifols, SA dividends here
What is Grifols, SA’s EPS estimate?
Grifols, SA’s EPS estimate is 0.2.
How many shares outstanding does Grifols, SA have?
Grifols, SA has 261,425,100 shares outstanding.
What happened to Grifols, SA’s price movement after its last earnings report?
Grifols, SA reported an EPS of €0.088 in its last earnings report, missing expectations of €0.139. Following the earnings report the stock price went up 0.631%.
Which hedge fund is a major shareholder of Grifols, SA?
Currently, no hedge funds are holding shares in GB:0RDV
Grifols Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€15.25 (99.09% Upside)
€15.25 (99.09% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.00%
12-Months-Change
Fundamentals
Return on Equity
3.37%
Trailing 12-Months
Asset Growth
-4.44%
Trailing 12-Months
Company Description
Grifols, SA
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2019. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 14% of revenue following the Novartis and Hologic deals.
Technical Analysis
Almirall
―
Bankinter
―
Faes Farma
―
Laboratorios Farmaceuticos Rovi
―
Pharma Mar SA
―